Transplantation
Pancreas Transplantation in Korea
Pancreas transplantation in South Korea — SPK, PAK, and PTA procedures for Type 1 diabetes and insulin-dependent conditions.
Quick Answer
- Simultaneous pancreas-kidney (SPK) transplant is the most common approach in Korea, accounting for roughly 84% of cases at leading centers — combining insulin independence with kidney restoration in one operation.
- Korea's organ allocation is managed by KONOS (Korean Network for Organ Sharing), a government-regulated body ensuring transparent deceased-donor matching; the KOTRY registry tracks long-term outcomes nationally.
- Living-donor segmental pancreas transplant is performed at select high-volume Korean centers, offering advantages such as shorter cold ischemia time and reduced waiting periods for eligible recipients.
At a Glance
| Procedure time | 4–8 hours (SPK); 3–5 hours (pancreas-alone) |
|---|---|
| Anesthesia | General anesthesia |
| Hospital stay | 3–5 weeks (initial surgical admission) |
| Recommended stay in Korea | 8–12 weeks including close outpatient follow-up |
| Recovery | Full functional recovery 3–6 months; immunosuppression lifelong |
Overview
Pancreas transplantation replaces a diseased or non-functional pancreas with a healthy donor organ, restoring the body's ability to produce insulin independently. It is primarily indicated for patients with Type 1 diabetes mellitus (T1DM) who experience severe glycemic instability or life-threatening hypoglycemia that cannot be controlled by insulin therapy alone.
Three main procedural variants are performed in South Korea:
- Simultaneous Pancreas-Kidney (SPK): A pancreas and kidney from the same deceased donor are transplanted in a single operation. This is the most common approach, suited for T1DM patients who also have diabetic nephropathy or end-stage renal disease.
- Pancreas After Kidney (PAK): A pancreas transplant performed after a prior kidney transplant, for patients who have already received or will receive a kidney from a living donor.
- Pancreas Transplant Alone (PTA): For patients with adequate kidney function but severe metabolic complications of diabetes.
A fourth option available at select Korean centers is living-donor segmental pancreas transplantation, where the distal body and tail of a living donor's pancreas are transplanted. This approach enables better HLA matching and shorter ischemia time compared to deceased-donor transplants.
South Korea has developed significant institutional expertise in all four approaches, supported by national registries, government-regulated organ allocation infrastructure, and high-volume transplant centers that have collectively performed hundreds of cases over multiple decades.
Start the KONOS waitlist process early
International patients seeking a deceased-donor transplant in Korea must be registered with KONOS. Eligibility rules for foreign nationals are subject to government regulation — confirm current requirements with the transplant coordinator before travel, as waitlist dynamics and international patient policies can change.
Living-donor transplant can shorten the wait
If you have a biologically compatible family member willing to donate, ask specifically about living-donor segmental pancreas transplant at centers with dedicated living-donor programs. It may reduce waiting time and can offer better HLA matching outcomes compared to a deceased-donor organ.
Am I a Candidate?
Not every patient with diabetes is a candidate. Transplant teams at Korean centers use rigorous multidisciplinary evaluation to determine suitability.
Typical indications for evaluation include:
- Type 1 diabetes mellitus with hypoglycemia unawareness, frequent severe hypoglycemic episodes, or consistently uncontrolled blood glucose despite optimal insulin therapy
- Diabetic nephropathy with declining kidney function (eGFR typically below 20 mL/min), making SPK the preferred route
- Intolerable quality-of-life impact from insulin-dependent diabetes
- Patients who have already received a kidney transplant and seek metabolic correction (PAK pathway)
Patients are generally excluded or require careful case-by-case review if they have:
- Significant cardiovascular disease that elevates surgical risk
- Active malignancy or uncontrolled infection
- Severe obesity (BMI thresholds vary by center)
- Substance use disorders or documented non-adherence to medical regimens
- Advanced age with multiple comorbidities, though age alone is not an absolute barrier
Foreign patients seeking evaluation in Korea typically undergo pre-arrival consultations, with medical records translated and reviewed by the transplant team. KONOS registration is required for deceased-donor waitlisting, and timelines for international patients vary. Living-donor transplants from a compatible family member can sometimes reduce waiting time significantly.
How the Procedure Works
All pancreas transplants in Korea are performed under general anesthesia in a major surgical facility with dedicated organ transplant teams including transplant surgeons, anesthesiologists, perfusionists, and intensive care specialists.
The general sequence for an SPK procedure:
- Pre-operative preparation: Final crossmatch testing, immunosuppression induction (typically with anti-thymocyte globulin or basiliximab), cardiac clearance, and bowel preparation.
- Organ procurement and cold preservation: The donor pancreas (and kidney in SPK) are procured by a separate surgical team and preserved in cold storage solution. Cold ischemia time is carefully minimized, as longer ischemia is associated with poorer graft function.
- Recipient surgery: The recipient's abdomen is opened via a midline incision. The donor pancreas is typically placed in the right iliac fossa, with vascular anastomoses connecting donor vessels to the recipient's iliac artery and vein. Exocrine drainage is handled by anastomosing the donor duodenal segment either to the recipient's small bowel (enteric drainage, the more widely used approach) or to the bladder.
- Kidney implantation (SPK): The donor kidney is placed in the left iliac fossa in the same operation, with separate vascular and ureteral anastomoses.
- Closure and ICU transfer: The abdomen is closed and the patient transferred to an intensive care or high-dependency unit for close monitoring.
For living-donor segmental pancreas transplant, only the distal pancreas (body and tail) is harvested from the donor, who retains the head of the pancreas. The donor undergoes a separate simultaneous surgery, and both procedures are coordinated by the same transplant team.
This approach is practiced at high-volume Korean centers with demonstrated experience in living-donor abdominal organ programs.
Recovery Timeline
Recovery from pancreas transplantation is extended and requires sustained medical supervision. Korean transplant centers typically plan for international patients to remain in-country for a minimum of 8 to 12 weeks after surgery.
Phase-by-phase timeline:
- ICU / step-down (Days 1–7): Intensive monitoring of graft function, blood glucose levels, fluid balance, and early signs of rejection or surgical complications such as thrombosis, bleeding, or anastomotic leak.
- General ward (Days 7–21): Transition to oral immunosuppression (typically a tacrolimus + mycophenolate mofetil + corticosteroid regimen), gradual dietary advancement, patient and caregiver education on medication adherence and self-monitoring.
- Hospital discharge to local accommodation (Weeks 3–5): Most uncomplicated SPK patients are discharged to nearby serviced accommodation. Outpatient visits occur 2–3 times per week for labs, tacrolimus level checks, and clinical assessment.
- Weeks 5–12 in Korea: Continued close follow-up, with decreasing visit frequency as labs stabilize. Biopsy may be performed if rejection is suspected.
- Return home (from ~Week 10–12): Coordination with the patient's home care team is established. Korean transplant coordinators provide detailed discharge summaries and immunosuppression protocols.
- Months 3–6: Gradual functional recovery, return to daily activities. Insulin requirements typically drop to zero in successful SPK and PTA recipients within days to weeks of a functioning graft.
- Long-term: Lifelong immunosuppression, annual follow-up, and metabolic monitoring. Rejection episodes requiring treatment can occur years after transplant.
Cost
Costs vary by hospital and case. Ask the hospital for a written, itemised estimate before you decide.
Why Korea
South Korea has built one of Asia's most comprehensive solid organ transplantation programs, underpinned by government infrastructure, national registries, and high procedural volumes at specialist centers.
KONOS (Korean Network for Organ Sharing), established under the Act on Organ Transplantation (2000), manages deceased-donor organ procurement, recipient matching, and allocation across the country. This centralized system ensures regulated, transparent, and equitable organ distribution — a critical quality-of-care factor for international patients.
KOTRY (Korean Organ Transplantation Registry), initiated in 2014, tracks outcomes for all solid organ transplant recipients nationally, enabling continuous quality improvement and providing a documented evidence base for survival and graft function rates.
Korea's transplant programs have particular depth in pancreas transplantation for Type 1 diabetes. High-volume centers have published outcomes showing 1-year and 5-year death-censored pancreas graft survival rates comparable to leading programs worldwide.
The availability of living-donor segmental pancreas transplant — less commonly offered outside specialized Asian centers — provides an additional pathway for eligible patients.
KHIDI and the Medical Korea portal actively support international patients through registered hospital networks, coordinator services, and visa facilitation specifically for medical travelers. Korea's healthcare system combines nationally accredited hospital quality with costs that are significantly lower than equivalent care in North America or Western Europe.
The concentration of transplant expertise in a small number of high-volume centers, rather than dispersal across many low-volume hospitals, supports the consistent team experience that complex procedures like SPK require.
Key Takeaways
- SPK is the dominant pancreas transplant procedure in Korea, combining pancreas and kidney restoration in a single operation for T1DM patients with renal disease.
- KONOS and KOTRY provide government-regulated organ allocation and national outcome tracking, underpinning the quality and transparency of Korea's transplant system.
- Living-donor segmental pancreas transplant is available at select high-volume Korean centers, offering an alternative pathway for eligible patients with a compatible donor.
- International patients should plan for 8–12 weeks in Korea post-surgery to cover the critical close-monitoring period before returning home.
- Lifelong immunosuppression after transplant requires ongoing coordination between the Korean transplant team and the patient's home medical team.
Frequently Asked Questions
Can international patients join the deceased-donor pancreas waiting list in Korea?
International patients can be registered with KONOS, Korea's national organ allocation body, but eligibility conditions and priority rules for foreign nationals are subject to government regulation that may change. Always confirm the current policy directly with the transplant center's international patient coordinator before making any travel or financial commitments.
How long will I need to stay in South Korea after a pancreas transplant?
Most transplant centers recommend staying in Korea for at least 8 to 12 weeks after surgery. The first 3 to 5 weeks are typically spent in hospital; the remaining time involves intensive outpatient monitoring — including blood draws, tacrolimus level checks, and clinical review — before the team considers it safe for you to travel home.
What is the difference between SPK, PAK, and PTA?
SPK (simultaneous pancreas-kidney) transplants both organs in one operation and is most common for Type 1 diabetes patients with kidney failure. PAK (pancreas after kidney) is for patients who have already received or plan to receive a kidney separately. PTA (pancreas transplant alone) is for patients with functioning kidneys but severe metabolic diabetes complications. Your transplant team will determine which pathway fits your clinical profile.
Is living-donor pancreas transplant available in Korea?
Yes. Select high-volume Korean transplant centers have published experience with living-donor segmental pancreas transplantation, where the distal body and tail of a compatible living donor's pancreas are transplanted. This can shorten waiting times and allows better pre-operative matching. Not every center offers this; ask specifically when contacting hospitals.
What immunosuppression will I need after a pancreas transplant?
Most recipients are maintained on a combination of tacrolimus, mycophenolate mofetil, and a low-dose corticosteroid. These medications must be taken for life. Dosing is titrated carefully during your stay in Korea, and a detailed protocol is provided to your home physician before you leave. Immunosuppression adherence is essential — stopping or missing doses is the most common cause of rejection.
How do Korean pancreas transplant outcomes compare internationally?
Published data from Korean transplant centers report 1-year and 5-year death-censored pancreas graft survival rates that are in line with outcomes published by leading programs in North America and Europe. Korea's national KOTRY registry enables continuous monitoring of outcomes across the system, supporting ongoing quality improvement.
Related Topics
Sources
International Patient Preparation Guides
Independent resources for international patients researching care in South Korea:
Researching Care in Korea?
KmedTour is an information resource only. Contact hospitals directly, or find a hospital registered to treat foreign patients on the Medical Korea portal.
Quick Facts
Cost
Ask the hospital for a written estimate
Duration
21 days
Korean Hospitals
0+ Available
Hospitals offering Pancreas Transplantation
Medical Information Disclaimer
The information provided on this page about Pancreas Transplantation is for general educational and informational purposes only. It is not intended as, and should not be construed as, medical advice, diagnosis, or treatment recommendations.
Always seek the advice of a qualified healthcare professional regarding any medical condition or treatment. Never disregard professional medical advice or delay seeking it because of information found on this website. Individual treatment outcomes may vary. Costs shown are estimates and may differ based on individual circumstances.
KmedTour is an independent information platform. It is not a medical provider or a registered foreign patient attraction agency, and it does not book treatment, take payment for treatment, or receive per-patient fees from hospitals. Treatment is arranged and paid for directly between you and the hospital.